medigraphic.com
ISSN 0210-5187 (Digital)

2009, Número 3

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2009; 37 (3)


Metástasis cutáneas de neoplasias internas

Martínez CL, Vilata CJJ

Idioma: Español
Referencias bibliográficas: 88
Paginas: 117-129
Archivo PDF: 906.79 Kb.


RESUMEN

Las metástasis cutáneas son un evento raro en dermatología, hay que tener en cuenta que pueden ser el primer marcador de la enfermedad y que así mismo pueden ser la primera señal de progresión. Generalmente las cutánides tienen la misma distribución por sexos que los primarios, siendo las cutánides más frecuentes en mujeres las procedentes de la mama, y en el hombre las procedentes de pulmón. Es importante reconocer estas lesiones para no diferir un diagnóstico correcto y por sus implicaciones con respecto al tratamiento. En aquellos pacientes con antecedentes de neoplasias internas, las metástasis cutáneas siempre hay que tenerlas dentro del diagnóstico diferencial de las lesiones cutáneas.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Costache M, Simionescu O, Sajin M, Chefani A. Cutaneous metastases carcinoma. Case report and pathological considerations. Rom J Morphol Embryol 2007; 48: 177-80.

  2. Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol 1995; 33 (2 Pt 1): 161-82.

  3. Kanitakis J. Cutaneous metastases of internal cancers. Presse Med 1993; 22: 631-6.

  4. Leonard N. Cutaneous metastases: Where do they come from and what can they mimic? Current Diagnostic Pathology 2007; 13: 320-30.

  5. Texier L, Genialux M, Tamisier J-M, Delaunay M-M, Plante C. Metastases cutanees des cancers digestifs. Ann Dermatol Venereol 1978; 105; 913-9.

  6. Navarrete Ortega M, Conde García J, García- Cantón JA. Cutaneous metastasis study of 66 cases. Actas Dermosifiliogr 1979; 70: 329-46.

  7. McKee PH. Cutaneous metastases. J Cutan Pathol 1985; 12: 239-50.

  8. Saeed S, Keehn CA, Morgan MB. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol 2004; 31: 419-30.

  9. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma:a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29: 228-36.

  10. White JW Jr. Evaluating cancer metastatic to the skin. Geriatrics 1985; 40: 67.

  11. Del Regato JA. Pathways of metastatic spread of malignant tumors. Semin Oncol 1977; 4: 33-8.

  12. Liotta LA, Kohn E. Cancer invasion and metastases. JAMA 1990; 263: 1123-6.

  13. Brownstein MH, Helwig EG. Spread of tumors to the skin. Arch Dermatol 1973; 107: 80-86.

  14. Hernanz JM, Vives P, García Almagro D, Jaqueti G. Neoplastic alopecia. Actas Dermosifiliogr 1979; 70: 507-14.

  15. Cuq-Viguier L, Viraben R. Zosteriform cutaneous metastases from squamous cell carcinoma of the stump of an amputated arm. Clin Exp Dermatol 1998; 23: 116-8.

  16. Tsen EH, Apisarnthanarax P. Inflammatory metastatic carcinoma of the breast. Arch Dermatol 1981; 117: 120-1.

  17. Edelstein JM. Pancreatic carcinoma with unusual metastasis to the skin and subcutaneous tissue simulating cellulitis. N Engl J Med 1950; 242: 779-81.

  18. Marcoval J, Gallego MI, Moreno A. Inflammatory cutaneous metastasis as a first sign of recurrence of squamous cell carcinoma of the lung. Actas Dermosifiliogr 2008; 99: 157-9.

  19. Reuter MJ, Nomland R. Inflammatory cutaneous metastatic carcinoma. Wis Med 1941; 40: 196-201.

  20. Kalajian AH, Piparo GF, Scalf LA, Kooper JA, Morgan MB. A baflinig basaloid brain. Am J Dermatopathol 2005; 27: 168-70.

  21. Bordel-Gómez MT, Used-Aznar MM. Metástasis cutáneas de origen primario desconocido. Actas Dermosifiliogr 2006; 97: 662-5.

  22. Powell FC, Cooper AJ, Massa MC, Goellner JR, Su WP. Sister Mary Joseph’s nodule: a clinical and histologic study. J Am Acad Dermatol 1984; 10: 610-5.

  23. Brownstein MH, Helwig EG. Patterns of cutaneous metastasis. Arch Dermatol 1972; 105: 862-8.

  24. Gül U, Kiliç A, Gönül M, Külcü Cakmak S, Erinçkan C. Spectrum of cutaneous metastases in 1287 cases of internal malignancies: a study from Turkey. Acta Derm Venereol 2007; 87: 160-2.

  25. Beautyman EJ, Garcia CJ, Sibulkin D. Transitional cell bladder cancer metastatic to the skin. Arch Dermatol 1983; 119: 705-7.

  26. Smith KJ, Williams J, Skelton H. Metastatic adenocarcinoma of the esofagus to the skin; new patterns of tumor recurrence and alternate treatments for palliation. J Cutan Pathol 2001; 28: 425-31.

  27. Dodiuk-Gad R, Ziv M, Loven D, Schafer J, Shani-Adir A, Dyachenko P, Rozenman D. Sister Mary Josh´s nodule as a presenting sign of internal malignancy. Skinmed 2006; 5: 256-8.

  28. Bansal R, Naik R. A study of 70 cases of cutaneous metastases from internal carcinoma. J Indian Med Assoc 1998; 96: 10-2.

  29. Chiu CS, Lin CY, Kuo TT, Kuan YZ, Chen MJ, Ho HC, et al. Malignant cutaneous tumors of the scalp: a study of demographic characteristics and histologic distributions of 398 Taiwanese patients. J Am Acad Dermatol 2007; 56: 448-52.

  30. Faust HB, Treadwell PA. Metastatic adenocarcinoma of the scalp mimicking a kerion. J Am acad dermatol 1993; 29: 654.

  31. Resnick KS, DiLeonardo M, Gibbons G. Clinically occult cutaneous metastases. J Am Acad Dermatol 2006; 55: 1044-7.

  32. Iwase K, Takenaka H, Oshima S, Kurozumi K, Nishimura Y, Yoshidome K, Tanaka T. The solitary cutaneous metastasis of asymptomatic colon cancer to an operative scar. Surg Today 1993; 23: 164-6.

  33. Nankhonya JM, Zakhour HD. Malignant seeding of needle aspiration tract: a rare complication. Br J Dermatol 1991; 124: 285-6.

  34. Brenner S, Tamir E, Maharshak N, Shapira J. Cutaneous manifestations of internal malignancies. Clin Dermatol 2001; 19: 290-7.

  35. Schwartz RA. Histopathologic aspects of cutaneous metastasic disease. J Am Acad dermatol 1995; 33: 649-57.

  36. Aguilar A, Schoendorff C, Lopez Redondo MJ, Ambrojo P, Requena L, Sanchez Yus E. Epidermotropic metastases from internal carcinomas. Am J Dermatopathol 1991; 13: 452-8.

  37. Requena L, Evaristo S, Nunez C, White C, Saguenza OP. Epidermotropically metastatic breast carcinomas: Rare histopathologic variants mimicking melanoma and Paget’s disease. Am J Dermatopathol 1996; 18: 385-95.

  38. Ambro CM, Humphreys TR, Lee JB. Epidermotropically metastatic pancreatic adenocarcinoma. Am J Dermatopathol 2006; 28: 60-2.

  39. Kummar S, Fogarasi M, Canova A, Mota A, Ciesielski T. Cytokeratin 7 and 20 staining for diagnosis of lung and colorectal adenocarcinoma. Br J Cancer 2002; 86: 1884-7.

  40. Park SY, Kim HS, Hong EK, Kim WH. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary. Hum Pathol 2002; 33: 1078-85.

  41. Wu SL, Kothari P, Wheeler TM, Reese T, Connely JH. Cytokeratins 7 and 20 immunoreactivity in the chromophobe renal cell carcinomas and renal oncocytomas. Mod Pathol 2002; 15: 712-7.

  42. Chu P, Wu E, Weiss LM. Cytokeratin 20 expression in epithelial neoplasms:a survey of 435 cases. Mod Pathol 2000; 13: 962-72.

  43. Azoulay S, Adem C, Pelletier FL, Barete S, Francès C, Capron F. Skin metastases from unknown origin: role of immunohistochemistry in the evaluation of cutaneous metastases of carcinoma of unknown origin. J Cutan Pathol 2005; 32: 561-6.

  44. Yasukawa K, Shimizu S, Yasui C, Sawamura D, Tsuchiya K. Cutaneous adenocarcinoma metastases associated with swelling of the neck and cheeks. Acta Derm Venereol 2004; 84: 399-400.

  45. Mortimer JE, Arquette MA, En Carey CF, Lee HH, Woeltje KF editors. The Washington Manual of medical Therapeutics. 20th ed. St. Luis, Missouri:Lippincott-Raven; 1999, pp. 379-81.

  46. García-Arpa M, Rodríguez-Vázquez M, Sánchez- Caminero P, Delgado M, Vera E, Romero G, Cortina P. Digital acrometastases. Actas Dermosifiliogr 2006; 97: 334-6.

  47. Camps Freneda A, Boleda M, Cerdán M, Méndez R, Debray N. Metastatic alopecia. Actas Dermosifiliogr 1979; 70: 313-7.

  48. Campbell FC, Herrington CS. Application of cytokeratin 7 and 20 immunohistochemistry to diagnostic pathology. Curr Diagnost Pathol 2001; 7: 113-22.

  49. Wauters CC, Smedts F, Gerrits LG. Keratins 7 and 20 as diagnostic markers of carcinomas metastatic to the ovary. Hum Pathol 1995; 26: 852-5.

  50. Mazoujian G, Bodian C, Haagensen DE Jr, Haagensen CD. Expresión of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Cancer 1989; 63: 2156-61.

  51. DeRienzo DP, Barr RJ. Metaplastic breast carcinoma histologically mimicking cutaneous spindle cell squamous cell carcinoma. Am J Dermatopathol 2005; 27: 250-4.

  52. Shamai-Lubovitz O, Rothem A, Ben-David E, Sandbank M, Hauben D. Cutaneous metastatic carcinoma of the breast mimicking malignant melanoma, clinically and histologically. J Am Acad Dermatol 1994; 31: 1058-60.

  53. Requena L, Saguenza M, saguenza OP, Kutzner H. Pigmented mammary Paget disease and pigmented epidermotropic metastases from breast carcinoma. Am J Dermatopathol 2002; 24: 189-98.

  54. Stroup RM, Pinkus GS. S100 immunoreactivity in primary and metastatic carcinoma of the breast. Hum Pathol 1988; 19: 949-53.

  55. Niikura H, Yoshida H, Ito K, Takano T, Watanabe H, Aiba S, Yaegashi N. Paget’s disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution. Int J Gynecol Cancer 2006; 16: 1212-5.

  56. Molina Garrido MJ, Guillén Ponce C, Soto Martínez JL, Martínez Y Sevila C, Carrato Mena A. Cutaneous metastases of lung cancer. Clin Transl Oncol 2006; 8: 330-3.

  57. Terashima T, Kanazawa M. Lung cancer with skin metastases. Chest 1994; 106: 1448-50.

  58. Yanagawa H, Hashimoto Y, Bando H. Intravascular bronchioloalveolar tumor with skin metastases. Chest 1994; 105: 1882-4.

  59. Brownstein MH, Helwig EB. Metastatic tumors to the skin. Cancer 1972; 29: 1298- 307.

  60. McKee PH. Cutaneous metastases. J Cutan Pathol 1985; 12: 239-50.

  61. Leech SN, Kolar AJ, Barret PD, Sinclair SA, Leonard N. Merkel cell carcinoma can be distinguished from metastatic small cell carcinoma using antibodies to cytokeratin 20 and thyroid transcription factor 1. J Clin Pathol 2001; 54: 727-9.

  62. Weedon D. In: Skin pathology, 2nd ed. Edinburgh: Churchill Livingstone 2002; pp. 1046-52.

  63. Eckert F, Schmidt U, Hardmeier T, Altmannsberger M. Cytokeratin expression in mucinous sweat gland carcinomas: an immunohistochemical analysis of four cases. Histopathology 1992; 21: 161-5.

  64. Nowak MA, Guerriere-Kovach P, Pathan A, Campbell TE, Deppisch LM. Perianal Paget’s disease: distinguishing primary and secondary lesions using immunohistochemical studies including gross cystic disease fluid protein-15 and cytokeratin 20 expression. Arch Pathol Lab Med 1998; 122: 1077-81.

  65. Khan AJ,Cook B. Metastatic carcinoma of the umbilicus: Sister Mary Joseph’s nodule. Cutis 1997; 60: 297.

  66. Koo DH, Chang HM, Jung JY, Song JH, Lee JL, Ryu MH et al. Cutaneous metastasis resembling acute dermatitis in a patient with advanced gastric cancer. Clin Exp Dermatol 2007; 32: 284-6.

  67. Jun DW, Lee OY, Park CK, Choi HS, Yoon BC, Lee MH, Lee DH. Cutaneous metastases of pancreatic carcinoma as a first clinical manifestation. Korean J Intern Med 2005; 20: 260-3.

  68. Yendluri V, Centeno B, Springett GM. Pancreatic cancer presenting as a Sister Mary Joseph’s nodule: case report and update of the literature. Pancreas 2007; 34: 161-4.

  69. Dauplat J, Hacker NF, Nieberg RK. Distant metastases in epithelial ovarian carcinoma. Cancer 1987; 60: 1561-6.

  70. Peñas PF, Jones-Caballero M, Amigo A, Aragüés M, García-Díez A. Cutaneous meningioma underlying congenital localizad hypertricosis. J Am Acad Dermatol 1994; 30: 363-6.

  71. Cormio G, Capotorto M, Vagno GD, Cazzolla A, Carriero C, Selvaggi L. Skin metastases in ovarian carcinoma: a report of nine cases and review of the literature. Gynec Oncol 2003; 90: 682-5.

  72. Baydar M, Dikilitas M, Sevinc A, Senel S, Senel F, Aydogdu I. Cutaneous metastasis of endometrial carcinoma with hemorrhagic nodules and papules. Eur J Gynaecol Oncol 2005; 26: 464-5.

  73. Lumpkin LR 3rd, Tschen JA. Renal cell carcinoma metastatic to the skin. Cutis 1984; 34: 143-4.

  74. Su WPD, Powell FC, Goellner JR. Malignant tumors metastatic to the skin: unusual illustrative cases. In: Wick MR, editor. Pathology of unusual malignant cutaneous tumours. New York: Marcel Dekker; 1985, pp. 357-97.

  75. Wong TY, Suster S, Nogita T, Duncan LM, Dickersin RG, Mihm MC Jr. Clear cell eccrine carcinomas of the skin. A clinicopathologic study of nine patients. Cancer 1994; 73: 1631-43.

  76. McGregor DK, Khurana KK, Cao C, Tsao CC, Ayala G, Krishnan B, Ro JY, Lechago J, Truong LD. Diagnosing primary and metastatic renal cell carcinoma: the use of the monoclonal antibody “Renal cell carcinoma marker”. Am J Surg Pathol 2001; 25: 1485-92.

  77. Herrera Puerto J, Herrera Flores J, Barragán Casas JM, Galán Velasco JJ. Cutaneous metastasis of a transitional-cell bladder carcinoma. Actas Urol Esp 2002; 26: 413-5.

  78. Schoenlaub P, Sarraux A, Grosshans E, Heid E, Cribier B. Survival after cutaneous metastasis: a study of 200 cases. Ann Dermatol Venereol 2001; 128: 1310-5.

  79. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Eng J Med 1993; 324: 357-63.

  80. Sariya D, Ruth K, Adams-McDonnell R, Cusack C, Xu X, Elenitsas R, Seykora et al. Clinicopathologic correlation of cutaneous metastases: experience from a cancer center. Arch Dermatol 2007; 143: 613-20.

  81. Hernandez-Pérez E, Cestoni-Parducci R. Nodular hidradenoma and hidradenocarcinoma: a 10-year review. J Am Acad Dermatol 1985; 12: 15-20.

  82. Volmar KE, Cummings TJ, Wang WH, Creager AJ, Tyler DS, Xie HB. Clear cell hidradenoma: a mimic of metastatic clear cell tumours. Arch Pathol Lab Med 2005; 129: e113-6.

  83. BahramiS, Malone JC, Lear S, Martin AW. CD10 expression in cutaneous adnexal neoplasms and a potential role for differenciating cutaneous metastatic renal cell carcinoma. Arch Pathol Lab Med 2006; 130: 1315-9.

  84. Wick MR, Goellner JR, Wolfe JT 3rd, Su WPD. Adnexal carcinomas of the skin, I: eccrine carcinomas. Cancer 1985; 56: 1147-62.

  85. Rosen T. Cutaneous metastases. Med Clin North Am 1980; 64: 885-900.

  86. Qureshi HS, Ormsby AH, Lee MW, Zarbo RJ, Ma CK. The diagnostic utility of p63, CK5/6, CK7 and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol 2004; 31: 145-52.

  87. Bayer-Garner IB, Smoller B. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site. Mod Pathol 2000;13: 119.

  88. Hiatt KM, Pillow JL, Smoller BR. Her-2 expression in cutaneous eccrine and apocrine neoplasms. Mod Pathol 2004; 17: 28-32.




2020     |     www.medigraphic.com